Abstract
The MRP family is composed of nine transporters, at least eight of which are lipophilic anion transporters that are capable of conferring resistance to various anticancer agents. Recently, mice with gene disruptions in Mrp2, Mrp3 and Mrp4 have been developed. This review will discuss insights into the physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 afforded by investigations of these new mouse models.
Similar content being viewed by others
Abbreviations
- CDF:
-
5-(and 6)-carboxy-2′,7′dichlorofluorescein
- DBSP:
-
dibromosulphthalein
- HPMPC:
-
1′-(3′-hydroxy-2-phosphonylmethoxypropyl)cytosine
- MRP:
-
multidrug resistance protein
- PMEA:
-
9′-(2′-phosphonylmethoxyethyl)-adenine
- PMPA:
-
9′-(2-phosphonomethoxypropyl)adenine
References
Kruh, G. D., & Belinsky, M. G. (2003). The MRP family of drug efflux pumps. Oncogene, 22, 7537–7552.
Borst, P., & Elferink, R. O. (2002). Mammalian ABC transporters in health and disease. Annu Rev Biochem, 71, 537–592.
Deeley, R. G., Westlake, C., & Cole, S. P. (2006). Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiological Reviews, 86, 849–899.
Nies, A. T., & Keppler, D. (2006). The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Archiv.
Borst, P., de Wolf, C., & van de Wetering, K. (2006). Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Archiv.
Kruh, G. D., Guo, Y., Hopper-Borge, E., Belinsky, M. G., & Chen, Z. S. (2006). ABCC10, ABCC11, and ABCC12. Pflugers Archiv.
Lorico, A., Rappa, G., Finch, R. A., Yang, D., Flavell, R. A., & Sartorelli, A. C. (1997). Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Research, 57, 5238–5242.
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A., Zaman, G. J., Mayer, U., et al. (1997). Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Natural Medicines, 3, 1275–1279.
Johnson, D. R., Finch, R. A., Lin, Z. P., Zeiss, C. J., & Sartorelli, A. C. (2001). The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice. Cancer Research, 61, 1469–1476.
Wijnholds, J., Scheffer, G. L., van der Valk, M., van der Valk, P., Beijnen, J. H., Scheper, R. J., et al. (1998). Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. Journal of Experimental Medicine, 188, 797–808.
Wijnholds, J., deLange, E. C, Scheffer, G. L., van den Berg, D. J., Mol, C. A., van der Valk, M., et al. (2000). Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. Journal of Clinical Investigation, 105, 279–285.
Robbiani, D. F., Finch, R. A., Jager, D., Muller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000). The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)- dependent mobilization of dendritic cells to lymph nodes. Cell, 103, 757–768.
Schultz, M. J., Wijnholds, J., Peppelenbosch, M. P., Vervoordeldonk, M. J., Speelman, P., van Deventer, S. J., et al. (2001). Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. Journal of Immunology, 166, 4059–4064.
Klement, J. F., Matsuzaki, Y., Jiang, Q. J., Terlizzi, J., Choi, H. Y., Fujimoto, N., et al. (2005). Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Molecular and Cellular Biology, 25, 8299–8310.
Gorgels, T. G, Hu, X., Scheffer, G. L., van der Wal, A. C., Toonstra, J., de Jong, P. T., et al. (2005). Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum. Human Molecular Genetics, 14, 1763–1773.
Jiang, Q., & Uitto, J. (2006). Pseudoxanthoma elasticum: A metabolic disease? Journal of Investigative Dermatology, 126, 1440–1441.
Gerk, P. M., & Vore, M. (2002). Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. Journal of Pharmacology and Experimental Therapeutics, 302, 407–415.
Jansen, P. L., Peters, W. H., & Lamers, W. H. (1985). Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology, 5, 573–579.
Hosokawa, S., Tagaya, O., Mikami, T., Nozaki, Y., Kawaguchi, A., Yamatsu, K., et al. (1992). A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions. Laboratory Animal Science, 42, 27–34.
Masuda, M., I’izuka, Y., Yamazaki, M., Nishigaki, R., Kato, Y., Ni’inuma, K., et al. (1997). Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Research, 57, 3506–3510.
Chu, X. Y., Kato, Y., Niinuma, K., Sudo, K. I., Hakusui, H., & Sugiyama, Y. (1997). Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. Journal of Pharmacology and Experimental Therapeutics, 281, 304–314.
Chu, X. Y., Strauss, J. R., Mariano, M. A., Li, J., Newton, D. J., Cai, X., et al. (2006). Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). Journal of Pharmacology and Experimental Therapeutics, 317, 579–589.
Vlaming, M. L., Mohrmann, K., Wagenaar, E., de Waart, D. R., Elferink, R. P., Lagas, J. S., et al. (2006). Carcinogen and anticancer drug transport by Mrp2 in vivo: Studies using Mrp2 (Abcc2) knockout mice. Journal of Pharmacology and Experimental Therapeutics, 318, 319–327.
Nezasa, K., Tian, X., Zamek-Gliszczynski, M. J., Patel, N. J., Raub, T. J., & Brouwer, K. L. (2006). Altered hepatobiliary disposition of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice. Drug Metabolism and Disposition, 34, 718–723.
Zamek-Gliszczynski, M. J., Xiong, H., Patel, N. J., Turncliff, R. Z., Pollack, G. M., & Brouwer, K. L. (2003). Pharmacokinetics of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein and its diacetate promoiety in the liver. Journal of Pharmacology and Experimental Therapeutics, 304, 801–809.
Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., et al. (1998). Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Molecular Pharmacology, 53, 1068–1075.
Konig, J., Rost, D., Cui, Y., & Keppler, D. (1999). Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology, 29, 1156–1163.
Chen, C., Slitt, A. L., Dieter, M. Z., Tanaka, Y., Scheffer, G. L., & Klaassen, C. D. (2005). Up-regulation of Mrp4 expression in kidney of Mrp2-deficient TR− rats. Biochemical Pharmacology, 70, 1088–1095.
van Aubel, R. A., Smeets, P. H., Peters, J. G., Bindels, R. J., & Russel, F. G. (2002). The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. Journal of the American Society of Nephrology, 13, 595–603.
Zamek-Gliszczynski, M. J., Nezasa, K., Tian, X., Kalvass, J. C., Patel, N. J., Raub, T. J., et al. (2006). The important role of bcrp (abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice. Molecular Pharmacology, 70, 2127–2133.
Lagas, J. S., Vlaming, M. L., van Tellingen, O., Wagenaar, E., Jansen, R. S., Rosing, H., et al. (2006). Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics. Clinical Cancer Research, 12, 6125–6132.
Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M., Smith, A. J., et al. (1999). MRP3, an organic anion transporter able to transport anti-cancer drugs. Proceedings of the National Academy of Sciences of the United States of America, 96, 6914–6919.
Zeng, H., Bain, L. J. Belinsky, M. G., & Kruh, G. D. (1999). Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Research 59, 5964–5967.
Zeng, H., Chen, Z.-S., Belinsky, M. G., Rea, P. A., & Kruh, G. D. (2001). Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: Effect of polyglutamylation on MTX transport. Cancer Research, 61, 7225–7232.
Hirohashi, T., Suzuki, H., & Sugiyama, Y. (1999). Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). Journal of Biological Chemistry, 274, 15181–15185.
Hirohashi, T., Suzuki, H., Takikawa, H., & Sugiyama, Y. (2000). ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). Journal of Biological Chemistry, 275, 2905–2910.
Zeng, H., Liu, G., Rea, P. A., & Kruh, G. D. (2000). Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Research, 60, 4779–4784.
Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M., Pijnenborg, A. C., Bosman, D. K., et al. (2002). Tissue distribution and induction of human multidrug resistant protein 3. Laboratory Investigation, 82, 193–201.
Belinsky, M. G., Bain, L. J., Balsara, B. B., Testa, J. R., & Kruh, G. D. (1998). Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. Journal of the National Cancer Institute, 90, 1735–1741.
Donner, M. G., & Keppler, D. (2001). Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology, 34, 351–359.
Soroka, C. J., Lee, J. M., Azzaroli, F., & Boyer, J. L. (2001). Cellular localization and up-regulation of multidrug resistance- associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology, 33, 783–791.
Benderra, Z., Faussat, A. M., Sayada, L., Perrot, J. Y., Tang, R., Chaoui, D., et al. (2005). MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia. Clinical Cancer Research, 11, 7764–7772.
Konig, J., Hartel, M., Nies, A. T., Martignoni, M. E., Guo, J., Buchler, M. W., et al. (2005). Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. International Journal of Cancer, 115, 359–367.
Oda, Y., Saito, T., Tateishi, N., Ohishi, Y., Tamiya, S., Yamamoto, H., et al. (2005). ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas. International Journal of Cancer, 114, 854–862.
Plasschaert, S. L., de Bont, E. S, Boezen, M., vander Kolk, D. M., Daenen, S. M., Faber, K. N., et al. (2005). Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clinical Cancer Research, 11, 8661–8668.
Steinbach, D., Wittig, S., Cario, G., Viehmann, S., Mueller, A., Gruhn, B., et al. (2003). The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood, 102, 4493–4498.
Belinsky, M. G., Dawson, P. A., Shchaveleva, I., Bain, L. J., Wang, R., Ling, V., et al. (2005). Analysis of the in vivo functions of Mrp3. Molecular Pharmacology, 68, 160–168.
Zelcer, N., Wetering, K. V., Waart, R. D., Scheffer, G. L., Marschall, H. U., Wielinga, P. R., et al. (2005). Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. Journal of Hepatology.
Dawson, P. A., Hubbert, M., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., et al. (2005). The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. Journal of Biological Chemistry, 280, 6960–6968.
Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P.A., Soroka, C. J., Boyer, J. L., et al. (2005). OSTalpha-OSTbeta: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology, 42, 1270–1279.
Zelcer, N., van de Wetering, K., Hillebrand, M., Sarton, E., Kuil, A., & Wielinga, P. R., et al. (2005). Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proceedings of the National Academy of Sciences of the United States of America, 102, 7274–7279.
Manautou, J. E., de Waart, D. R., Kunne, C., Zelcer, N., Goedken, M., Borst, P., et al. (2005). Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology, 42, 1091–1098.
Zamek-Gliszczynski, M. J., Nezasa, K. I., Tian, X., Bridges, A. S., Lee, K., Belinsky, M. G., et al. (2006). Evaluation of the role of Mrp3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3(−/−) and Abcc4(−/−) mice. Journal of Pharmacology and Experimental Therapeutics.
Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., & Borst, P. (2001). Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). Journal of Biological Chemistry, 276, 46400–46407.
Bohan, A., Chen, W. S., Denson, L. A., Held, M. A., & Boyer, J. L. (2003). Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. Journal of Biological Chemistry, 278, 36688–36698.
Mennone, A., Soroka, C. J., Cai, S. Y., Harry, K., Adachi, M., Hagey, L., et al. (2006). Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology, 43, 1013–1021.
Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., & Kruh, G. D. (1998). Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Research, 58, 2741–2747.
Chen, Z.-S., Lee, K., & Kruh, G. D. (2001). Transport of cyclic nucleotides and estradiol 17-β-d-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. Journal of Biological Chemistry, 276, 33747–33754.
Chen, Z.-S., Lee, K., Walther, S., Blanchard Raftogianis, R., Kuwano, M., Zeng, H., et al. (2002). Analysis of methotrexate and folate transport by multidrug resistance protein 4: MRP4 is a component of the methotrexate efflux system. Cancer Research, 62, 3144–3150.
Jedlitschky, G., Burchell, B., & Keppler, D. (2000). The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. Journal of Biological Chemistry, 275, 30069–30074.
Wielinga, P. R., Van Der Heijden, I., Reid, G., Beijnen, J. H., Wijnholds, J., & Borst, P. (2003). Characterization of the MRP4-and MRP5-mediated transport of cyclic nucleotides from intact cells. Journal of Biological Chemistry 278, 17664–17671.
Chen, Z. S., Guo, Y., Belinsky, M. G., Kotova, E., & Kruh, G. D. (2005). Transport of bile acids, sulfated steroids, estradiol 17-beta-d-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Molecular Pharmacology, 67, 545–557.
Guo, Y., Kotova, E., Chen, Z.-S., Lee, K., Hopper-Borge, E., Belinsky, M. G., et al. (2003). MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines, 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. Journal of Biological Chemistry, 278, 29509–29514.
Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., & Keppler, D. (2003). Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology, 38, 374–384.
Reid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., et al. (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proceedings of the National Academy of Sciences of the United States of America, 100, 9244–9249.
Rius, M., Thon, W. F., Keppler, D., & Nies, A. T. (2005). Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. Journal of Urology, 174, 2409–2414.
Zelcer, N., Reid, G., Wielinga, P., Kuil, A., Van Der Heijden, I., Schuetz, J. D., et al. (2003). Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochemical Journal, 371, 361–367.
Van Aubel, R. A., Smeets, P. H., van den Heuvel, J. J., & Russel, F. G. (2005). Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol, 288, F327–F333.
Lai, L., & Tan, T. M. (2002). Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)- mediated efflux of cAMP and resistance to purine analogues. Biochemical Journal, 361, 497–503.
Borst, P., Zelcer, N., van de Wetering, K., & Poolman, B. (2006). On the putative co-transport of drugs by multidrug resistance proteins. FEBS Letters, 580, 1085–1093.
Lee, K., Klein-Szanto, A. J., & Kruh, G. D. (2000). Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. Journal of the National Cancer Institute, 92, 1934–1940.
Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., et al. (1999). MRP4: A previously unidentified factor in resistance to nucleoside- based antiviral drugs. Natural Medicines, 5, 1048–1051.
Adachi, M., Sampath, J., Lan, L. B., Sun, D., Hargrove, P., Flatley, R., et al. (2002). Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. Journal of Biological Chemistry, 277, 38998–39004.
Wielinga, P. R., Reid, G., Challa, E. E., van der Heijden, I., van Deemter, L., de Haas, M., et al. (2002). Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Molecular Pharmacology, 62, 1321–1331.
Leggas, M., Adachi, M., Scheffer, G. L., Sun, D., Wielinga, P., Du, G., et al. (2004). Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Molecular and Cellular Biology, 24, 7612–7621.
Norris, M. D., Smith, J., Tanabe, K., Tobin, P., Flemming, C., Scheffer, G. L., et al. (2005). Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Mol Cancer Ther, 4, 547–553.
Tian, Q., Zhang, J., Tan, T. M., Chan, E., Duan, W., Chan, S. Y., et al. (2005). Human multidrug resistance associated protein 4 confers resistance to camptothecins. Pharmaceutical Research, 22, 1837–1853.
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., et al. (1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Research, 57, 3537–3547.
Denk, G. U., Soroka, C. J., Takeyama, Y., Chen, W. S., Schuetz, J. D., & Boyer, J. L. (2004). Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. Journal of Hepatology 40, 585–591.
Szakacs, G., Annereau, J.-P., Lababidi, S., Shankavaram, U., Arciello, A., Bussey, K. J., et al. (2004). Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells. Cancer Cell.
Steinbach, D., Lengemann, J., Voigt, A., Hermann, J., Zintl, F., & Sauerbrey, A. (2003). Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia. Clinical Cancer Research, 9, 1083–1086.
Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., et al. (2001). Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. Journal of Biological Chemistry, 276, 39411–39418.
Belinsky, M. G., Guo, P., Lee, K., Zhou, F., Kotova, E., Grinberg, A., et al. (2007). Multidrug resistance protein 4 (Mrp4) protects bone marrow, thymus, spleen and intestine from nucleotide analog-induced damage. Cancer Research, 67, 262–268.
Imaoka, T., Kusuhara, H., Adachi, M., Schuetz, J. D., & Takeuchi, K., Sugiyama, Y. (2006). Functional involvement of multidrug resistance associated protein 4 (MRP4/ABCC4) in the renal elimination of the anti-viral drugs, adefovir and tenofovir. Molecular Pharmacology.
Maher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., Klaassen, C. D. (2005). Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metabolism and Disposition, 33, 947–955.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kruh, G.D., Belinsky, M.G., Gallo, J.M. et al. Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer Metastasis Rev 26, 5–14 (2007). https://doi.org/10.1007/s10555-007-9039-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-007-9039-1